⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
PFIZER - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.7
| Stock Code | PFIZER | Market Cap | 22,045 Cr. | Current Price | 4,823 ₹ | High / Low | 5,993 ₹ |
| Stock P/E | 29.0 | Book Value | 841 ₹ | Dividend Yield | 0.73 % | ROCE | 21.6 % |
| ROE | 16.4 % | Face Value | 10.0 ₹ | DMA 50 | 4,869 ₹ | DMA 200 | 4,976 ₹ |
| Chg in FII Hold | 0.11 % | Chg in DII Hold | -0.06 % | PAT Qtr | 182 Cr. | PAT Prev Qtr | 189 Cr. |
| RSI | 48.8 | MACD | -46.1 | Volume | 13,644 | Avg Vol 1Wk | 41,280 |
| Low price | 3,701 ₹ | High price | 5,993 ₹ | PEG Ratio | 18.3 | Debt to equity | 0.01 |
| 52w Index | 49.0 % | Qtr Profit Var | 43.0 % | EPS | 187 ₹ | Industry PE | 27.6 |
📊 Technical Analysis
- Chart Patterns: Stock is trading close to both 50-DMA (₹4,869) and 200-DMA (₹4,976), showing sideways consolidation.
- Moving Averages: Current price ₹4,823 is slightly below both DMAs, indicating mild bearish bias.
- RSI: 48.8 — neutral zone, neither overbought nor oversold.
- MACD: -46.1 — bearish crossover, weak momentum.
- Bollinger Bands: Price near mid-band, suggesting consolidation.
- Volume Trends: Current volume (13.6K) is significantly below 1-week average (41.2K), showing weak participation.
📈 Momentum & Signals
- Short-term Momentum: Neutral to weak, consolidation phase.
- Entry Zone: ₹4,700–₹4,823 (support levels).
- Exit Zone: ₹4,869–₹4,976 (resistance levels).
- Trend Status: Stock is consolidating with mild bearish bias.
✅ Positive
- Strong ROCE (21.6%) and ROE (16.4%) indicate efficient capital use.
- Low debt-to-equity (0.01), virtually debt-free.
- EPS of ₹187 shows solid earnings base.
⚠️ Limitation
- High PEG ratio (18.3) suggests expensive valuation relative to growth.
- Quarterly PAT declined slightly (₹182 Cr vs ₹189 Cr).
- Weak trading volumes, showing lack of momentum.
📰 Company Negative News
- Quarterly PAT dipped marginally, showing near-term earnings pressure.
- DII holdings decreased (-0.06%), indicating reduced domestic institutional support.
🌟 Company Positive News
- FII holdings increased (+0.11%), showing foreign investor confidence.
- Quarterly profit variance +43.0% YoY indicates strong growth trend.
🏭 Industry
- Industry P/E at 27.6, slightly lower than company’s P/E (29.0), suggesting Pfizer trades at a premium.
- Pharmaceutical sector remains resilient with steady demand outlook.
🔎 Conclusion
- Stock is consolidating near support levels with neutral momentum.
- Short-term traders may consider entry near ₹4,700–₹4,823 with exit around ₹4,869–₹4,976.
- Medium-term investors may hold for stability, but valuation appears stretched relative to industry peers.